Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Kids are more likely to maintain a healthy weight if their parents adopt a responsive style while they're babies and toddlers ...

“By fostering early-life responsive parenting practices, we can help establish healthy growth trajectories that may reduce ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

This form of exercise is found to be especially beneficial for women and middle-aged and older adults, particularly those ...

Novo Nordisk stock tumbled Monday morning after disappointing trial results for its CagriSema weight-loss drug. Shares in ...

New trial data showed the drug helped obese or overweight type 2 diabetics lose an average 15.7% of their weight, when an ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

New research set to be presented at the European Congress on Obesity (ECO 2025) suggests that marriage significantly ...

A Polish health survey found that being married increased risk of overweight in women and men, with the latter group also experiencing three times the risk of obesity.

After a long, stressful day at work, or when pressed for time, the temptation to have a quick, satisfying snack—like crisps ...